Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Psychotropic medications for anxiety and behavior
4 evidence topics · 2 sources
Consensus guideline: screening for anxiety and depression and selective serotonin reuptake inhibitors
“Screen for caregiver impressions of anxiety and depression, such as withdrawal; these may become more prominent with age or in individuals with milder clinical presentations. Identify possible contributors (eg, sedating medications, decreased social interaction, limited access to engaging activities). Consider treatment with a selective serotonin reuptake inhibitor such as escitalopram which may have a lower risk of inducing a prolonged QTc interval.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Families should be encouraged to disclose use of alternative medications (cannabis, oils and so on) to all specialists.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Natural History Study: absence of anxiety management guidelines
“In spite of the general impression that anxiety-like behavior is common in individuals with RTT, no systematic studies of anxiolytics use have been reported in this population and guidelines for clinical management of anxiety in RTT do not exist.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Natural History Study: frequency of anxiolytic and SSRI use
“Parental reports and medication logs provided data from 1380 females with RTT participating in two iterations of the multicenter U.S. RTT Natural History Study (RNHS) from 2006 to 2019.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Parents directly reported treatment for anxious or nervous behavior in 16.6% of participants in the second iteration with most reporting good control of the behavior (71.6%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“15.0% of participants in the first and 14.5% in the second (P = 0.835). The most commonly used drugs were escitalopram, sertraline, fluoxetine, and buspirone.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Based on medication logs, SSRI use for any indication was reported for 13.1% of participants in the first iteration and 11.0% in the second iteration (P = 0.414).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Increased use of anxiolytics and selective serotonin reuptake inhibitors (SSRIs) was related to more frequent anxiety-like behaviors (P < 0.001), older age (P < 0.001), and mild MECP2 variants (P = 0.002).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote